The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Thromboembolism in Hospitalized Neutropenic Cancer Patients
Abstract
Purpose: Cancer is associated with thrombosis, but the frequency of thromboembolism in hospitalized cancer patients receiving current chemotherapy regimens is not known. We investigated venous and arterial thromboembolism and associated outcomes in hospitalized cancer patients actively receiving therapy, as identified by neutropenia. Methods: We conducted a retrospective cohort study using the discharge database of the University HealthSystem Consortium. This included 66,106 adult neutropenic cancer patients with 88,074 hospitalizations between 1995 and 2002 at 115 medical centers in the United States. Results: Thromboembolism was reported in 5,272 patients (8%), with 5.4% patients developing venous thromboembolism and 1.5% developing arterial thromboembolism during the first hospitalization. Patients with lymphoma and leukemia accounted for one third of venous and nearly one half of arterial events. Clinical variables most frequently associated with thromboembolism were age ≥ 65 years; primary site of cancer, including lung, GI, gynecologic, and brain; and comorbidities, including infection, pulmonary and renal disease, and obesity. In-hospital mortality was significantly greater in patients with venous (odds ratio [OR] = 2.01; 95% CI, 1.83 to 2.22) or arterial thromboembolism (OR = 5.04; 95% CI, 4.38 to 5.79). From 1995 to 2002, there was a 36% increase in venous events and a 124% increase in arterial events (P < .0001 for trend). Conclusion: Thromboembolism is frequent in hospitalized neutropenic cancer patients, including in perceived low-risk subgroups such as patients with hematologic malignancies and nonmetastatic disease, and seems to be increasing. Thromboembolism is associated with increased in-hospital mortality. Increased efforts at thromboprophylaxis are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.809 · Cited by 2,171
Prognosis of Cancers Associated with Venous Thromboembolism
Sørensen, H. T., Mellemkjær, L., Olsen, J. H., & Baron, J. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432504 · Cited by 1,628
Samama, M. M., Cohen, A. T., Darmon, J.-Y., Desjardins, L., Eldor, A., Janbon, C., Leizorovicz, A., Nguyen, H., Olsson, C.-G., Turpie, A. G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411103 · Cited by 1,584
Levitan, N., Dowlati, A., Remick, S. C., Tahsildar, H. I., Sivinski, L. D., Beyth, R., & Rimm, A. A. (1999) · Medicine · doi:10.1097/00005792-199909000-00001 · Cited by 891
Venous Thromboembolism and Cancer: Risks and Outcomes
Lee, A. Y. Y., & Levine, M. N. (2003) · Circulation · doi:10.1161/01.cir.0000078466.72504.ac · Cited by 721
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells
Palumbo, J. S., Kombrinck, K. W., Drew, A. F., Grimes, T. S., Kiser, J. H., Degen, J. L., & Bugge, T. H. (2000) · Blood · doi:10.1182/blood.v96.10.3302 · Cited by 605
The Epidemiology of Diagnosed Pulmonary Embolism and Deep Venous Thrombosis in the Elderly
Kniffin, W. D. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.8.861 · Cited by 529
Infection and inflammation and the coagulation system
Levi, M. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00857-x · Cited by 517
Levine, M., Hirsh, J., Arnold, A., Gent, M., Levine, M., Arnold, A., Bramwell, V., Pritchard, K. I., Stewart, D., Warr, D., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90008-6 · Cited by 510
Venous Thrombosis in Patients with Solid Tumors: Determination of Frequency and Characteristics
Wan, J., Nguyen, N., & Sallah, S. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613051 · Cited by 411
Tissue Factor, Thrombin, and Cancer
Rickles, F. R., Patierno, S., & Fernandez, P. M. (2003) · Chest · doi:10.1378/chest.124.3_suppl.58s · Cited by 378
Zacharski, L. R., Henderson, W. G., Rickles, F. R., Forman, W. B., Cornell, C. J., Forcier, A. J., Edwards, R. L., Headley, E., Kim, S.-H., O'Donnell, J. F., et al. (1984) · Cancer · doi:10.1002/1097-0142(19840515)53:10<2046::aid-cncr2820531007>3.0.co;2-f · Cited by 343
Causes of death in cancer patients.
Ambrus, J. L., Ambrus, C. M., Mink, I. B., & Pickren, J. W. (1975) · PubMed · Cited by 282
Outcomes and Cost of Deep Venous Thrombosis Among Patients With Cancer
Elting, L. S., Escalante, C. P., Cooksley, C., Avritscher, E. B. C., Kurtin, D., Hamblin, L., Khosla, S. G., & Rivera, E. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.15.1653 · Cited by 269
Venous Thromboembolism According to Age: The Impact of an Aging Population
Stein, P. D., Hull, R. D., Kayali, F., Ghali, W. A., Alshab, A. K., & Olson, R. E. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.20.2260 · Cited by 254
Venous Thrombosis in Cancer Patients: Insights from the FRONTLINE Survey
Kakkar, A. K., Levine, M., Pinedo, H. M., Wolff, R., & Wong, J. (2003) · The Oncologist · doi:10.1634/theoncologist.8-4-381 · Cited by 207
Epidemiology of Thrombosis in Cancer
Rickles, F. R., & Levine, M. N. (2001) · Acta Haematologica · doi:10.1159/000046583 · Cited by 200
Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism
Undas, A., Sydor, W., Brummel, K. E., Musiał, J., Mann, K. G., & Szczeklik, A. (2003) · Circulation · doi:10.1161/01.cir.0000047062.03282.a3 · Cited by 189
Malignancy, thrombosis and Trousseau: the case for an eponym
Khorana, A. A. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2003.00501.x · Cited by 166
Self-citationKhorana, A. A., Sahni, A., Altland, O. D., & Francis, C. W. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000090671.56682.d7 · Cited by 149
Self-citationWun, T., Law, L. Y., Harvey, D. J., Sieracki, B., Scudder, S., & Ryu, J. K. (2003) · Cancer · doi:10.1002/cncr.11700 · Cited by 139
Infections and endothelial cells
Keller, T. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00354-7 · Cited by 116
Thalidomide and Deep Vein Thrombosis in Multiple Myeloma: Risk Factors and Effect on Survival
Zangari, M., Barlogie, B., Thertulien, R., Jacobson, J. L., Eddleman, P., Fink, L. M., Fassas, A., van Rhee, F., Talamo, G., Lee, C.-K., et al. (2003) · Clinical Lymphoma · doi:10.3816/clm.2003.n.011 · Cited by 112
Pathogenesis of Thrombosis in Patients with Malignancy
Falanga, A., & Donati, M. B. (2001) · International Journal of Hematology · doi:10.1007/bf02981929 · Cited by 111
Bryant, A. E. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.451-462.2003 · Cited by 108
Blood Coagulation and Thrombosis in Patients with Ovarian Malignancy
Tempelhoff, G.-F. V., Dietrich, M., Niemann, F., Schneider, D. M., Hommel, G., & Heilmann, L. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655988 · Cited by 103
Lectures ON CLINICAL MEDICINE,
Walshe, W. H. (1849) · The Lancet · doi:10.1016/s0140-6736(02)65117-7 · Cited by 97
Potentiation of Endothelial Cell Proliferation by Fibrin(ogen)-bound Fibroblast Growth Factor-2
Sahni, A., Sporn, L. A., & Francis, C. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.14936 · Cited by 92
Self-citationStein, P. D., Hull, R. D., Ghali, W. A., Patel, K. C., Olson, R. E., Meyers, F. A., & Kalra, N. K. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.10.1213 · Cited by 71
Thrombosis in Cancer Patients Treated with Hematopoietic Growth Factors - A Meta-Analysis
Barbul, T., Finazzi, G., Grassi, A., & Marchioli, R. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650276 · Cited by 70
Solit, D. B., Morris, M. J., Slovin, S. F., Curley, T., Schwartz, L. H., Larson, S. M., Kattan, M. W., Hartley‐Asp, B., Scher, H. I., & Kelly, W. K. (2003) · Cancer · doi:10.1002/cncr.11754 · Cited by 32
Rosenman, M. B., Madsen, K. A., Hui, S. L., & Breitfeld, P. P. (2002) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200205000-00009 · Cited by 25
Cited by
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
Prevention of Venous Thromboembolism
Geerts, W. H., Bergqvist, D., Pineo, G. F., Heit, J. A., Samama, C. M., Lassen, M. R., & Colwell, C. W. (2008) · Chest · doi:10.1378/chest.08-0656 · Cited by 3,829
Kahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
Development and validation of a predictive model for chemotherapy-associated thrombosis
Khorana, A. A., Kuderer, N. M., Culakova, E., Lyman, G. H., & Francis, C. W. (2008) · Blood · doi:10.1182/blood-2007-10-116327 · Cited by 2,217
Self-citationThromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
KHORANA, A. A., FRANCIS, C. W., CULAKOVA, E., KUDERER, N. M., & LYMAN, G. H. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02374.x · Cited by 1,670
Self-citation
Metadata
- Authors
- Khorana, A. A., Francis, C. W., Culakova, E., Fisher, R. I., Kuderer, N. M., & Lyman, G. H.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-01-20
- Volume
- 24
- Issue
- 3
- Pages
- 484-490
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2103029594
- Cited by
- 475
- References
- 32
- FWCI
- 22.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.